114 related articles for article (PubMed ID: 9071918)
1. 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.
Kok TC; van der Gaast A; Splinter TA
Eur J Cancer; 1997 Jan; 33(1):165-6. PubMed ID: 9071918
[No Abstract] [Full Text] [Related]
2. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Massimini G; Holdener EE; Krakoff IH
J Natl Cancer Inst; 1993 Mar; 85(6):499-500. PubMed ID: 8445678
[No Abstract] [Full Text] [Related]
3. 13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial.
Slabber CF; Falkson G; Burger W; Schoeman L
Invest New Drugs; 1996; 14(4):391-4. PubMed ID: 9157075
[TBL] [Abstract][Full Text] [Related]
4. Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN).
Toma S; Airoldi M; Palumbo R; Raffo P; Bumma C
Int J Cancer; 1997 Feb; 70(4):491-3. PubMed ID: 9033664
[No Abstract] [Full Text] [Related]
5. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP
Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124
[TBL] [Abstract][Full Text] [Related]
6. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
[TBL] [Abstract][Full Text] [Related]
7. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.
Voravud N; Lippman SM; Weber RS; Rodriquez GI; Yee D; Dimery IW; Earley CL; Von Hoff DD; Hong WK
Invest New Drugs; 1993 Feb; 11(1):57-60. PubMed ID: 8349437
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract][Full Text] [Related]
11. Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.
Buer J; Probst M; Ganser A; Atzpodien J
J Clin Oncol; 1995 Oct; 13(10):2679-80. PubMed ID: 7595723
[No Abstract] [Full Text] [Related]
12. Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma.
Toma S; Palumbo R; Vincenti M; Aitini E; Paganini G; Pronzato P; Grimaldi A; Rosso R
Ann Oncol; 1994 May; 5(5):463-5. PubMed ID: 8075053
[TBL] [Abstract][Full Text] [Related]
13. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon.
Wadler S; Fell S; Haynes H; Katz HJ; Rozenblit A; Kaleya R; Wiernik PH
Cancer; 1993 Mar; 71(5):1726-30. PubMed ID: 8448736
[TBL] [Abstract][Full Text] [Related]
14. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
15. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.
Lippman SM; Donovan DT; Frankenthaler RA; Weber RS; Earley CL; Hong WK; Goepfert H
J Natl Cancer Inst; 1994 Jun; 86(11):859-61. PubMed ID: 8182767
[No Abstract] [Full Text] [Related]
16. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G
Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916
[No Abstract] [Full Text] [Related]
17. Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.
Piamsomboon S; Termrungruanglert W; Kudelka AP; Edwards CL; Freedman RS; Mountain CF; Delclos L; Aapro MS; DeCaro L; Bianca J; Verschraegen CF; Kavanagh JJ
Anticancer Drugs; 1996 Sep; 7(7):800-4. PubMed ID: 8949994
[TBL] [Abstract][Full Text] [Related]
18. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
19. Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy.
Tauber M; Monsel G; Bonnecarrère L; Battistella M; Cordel N; Honein C; Aubin F; Bagot M; Petit A; Lebbé C; Viguier M
Acta Derm Venereol; 2014 Nov; 94(6):721-2. PubMed ID: 24676771
[No Abstract] [Full Text] [Related]
20. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
